CAS Medical Systems — Merger or Acquisition (February 2019)
9 slides from CAS Medical Systems's merger presentation, Feb 12, 2019

Slide 1: Edwards Update
Confidential # 1 Edwards Update Tom Patton

Slide 2: Forward-Looking Statements
Confidential # 2 Forward - Looking Statements Certain statements contained in this communication may constitute “forward - looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements regarding the expect

Slide 3: Agrees to be acquired by Edwards: $2.45 per share
Confidential # 3 agrees to be acquired by • $2.45 per share • Estimated Transaction Close: - Q2 2019 - Business as usual between now and then! - More information to come

Slide 4: Who is Edwards Lifesciences?
Confidential # 4 Who is Edwards Lifesciences? • The global leader in patient - focused innovations for structural heart disease and critical care monitoring ▪ Headquarters in Irvine, California ▪ 2018 sales: $3.8 billion ▪ ~13,000 global employees ▪ Business units: Critical Care , Surgical Structura

Slide 5: Edwards' Culture is Driven by its Credo and Patient Focus
Confidential # 5 Edwards’ Culture is Driven by its Credo and Patient Focus Through our actions, we will become trusted partners with customers, colleagues, and patients – creating a community unified in its mission to improve the quality of life around the world. Our results will benefit customers,

Slide 6: What does this mean for me?
Confidential # 6 What does this mean for me? • Business “as usual” • Thoughtful integration planning to start in earnest after close of the transaction in the second quarter • Some basic “day 1” readiness activities will commence soon to reduce disruption to you ▪ No delays in payroll ▪ No time gap

Slide 7: What is our CASMED Legacy?
Confidential # 7 What is our CASMED Legacy? • We transformed CASMED into a high - margin, high - growth, medical disposables company with 90% recurring revenues • We serviced customers to a 99% customer retention rate! • We nurtured FORE - SIGHT from a nascent technology, to an industry leading posi

Slide 8: What is our CASMED Legacy? Our Values
Confidential # 8 What is our CASMED Legacy? We did it all consistent with our Values: 1. We have acted with integrity in all that we do. 2. Improving patient care has been our passion. 3. Excellence has been our standard. 4. The CASMED team has been our greatest asset. 5. We have been accountable .

Slide 9: What's Next?
Confidential # 9 What’s Next? • We expect transaction to close in Q2 2019. • Until then, it is: BUSINESS AS USUAL !! Questions?
Source: SEC EDGAR · DEFA14A filed Feb 12, 2019